{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T04:18:43Z","timestamp":1784261923183,"version":"3.55.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1053\/j.ajkd.2025.09.024","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T23:54:18Z","timestamp":1766447658000},"page":"433-442","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Optimizing Comprehensive Medication Management in CKD: An Opportunity to Integrate Pharmacists in the Kidney Care Team"],"prefix":"10.1053","volume":"87","author":[{"given":"Joanna Q.","family":"Hudson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex R.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda J.","family":"Condon Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Maxson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calvin J.","family":"Meaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy L.","family":"St. Peter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6 suppl 1","key":"10.1053\/j.ajkd.2025.09.024_bib1","doi-asserted-by":"crossref","first-page":"A8","DOI":"10.1053\/j.ajkd.2025.02.602","article-title":"US Renal Data System 2024 annual data report: epidemiology of kidney disease in the United States","volume":"85","author":"Johansen","year":"2025","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2025.09.024_bib3","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","article-title":"Cardiovascular-kidney-metabolic health: a Presidential Advisory from the American Heart Association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"key":"10.1053\/j.ajkd.2025.09.024_bib4","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1053\/j.ackd.2020.07.007","article-title":"Current state of the workforce in nephrology","volume":"27","author":"Lederer","year":"2020","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1053\/j.ajkd.2025.09.024_bib5","doi-asserted-by":"crossref","first-page":"915","DOI":"10.2215\/CJN.0000000716","article-title":"The emerging nephrology physician workforce in the United States: defining an impending shortfall","volume":"20","author":"Silvestre","year":"2025","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2025.09.024_bib6","doi-asserted-by":"crossref","first-page":"816","DOI":"10.2215\/CJN.0000000000000133","article-title":"Reimagining nephrology fellowship education to meet the future needs of nephrology: a report of the American Society of Nephrology Task Force on the Future of Nephrology","volume":"18","author":"Rosenberg","year":"2023","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2025.09.024_bib7","article-title":"Medication burden in patients with dialysis-dependent CKD: a systematic review","volume":"46","author":"Liu","year":"2024","journal-title":"Ren Fail"},{"key":"10.1053\/j.ajkd.2025.09.024_bib8","doi-asserted-by":"crossref","first-page":"841","DOI":"10.34067\/KID.0000000000000447","article-title":"Polypharmacy in patients with CKD: a systematic review and meta-analysis","volume":"5","author":"Oosting","year":"2024","journal-title":"Kidney360"},{"key":"10.1053\/j.ajkd.2025.09.024_bib9","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.2215\/CJN.00290109","article-title":"Pill burden, adherence, hyperphosphatemia, and quality of life in maintenance dialysis patients","volume":"4","author":"Chiu","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2025.09.024_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2022.100564","article-title":"Disparities in SGLT2 inhibitor or glucagon-like peptide 1 receptor agonist initiation among Medicare-insured adults with CKD in the United States","volume":"5","author":"Zhao","year":"2023","journal-title":"Kidney Med"},{"key":"10.1053\/j.ajkd.2025.09.024_bib12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1681\/ASN.0000000000000477","article-title":"Sodium-glucose cotransporter-2 inhibitor and glucagon-like peptide-1 receptor agonist discontinuation in patients with CKD","volume":"36","author":"Gregg","year":"2025","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2025.09.024_bib14","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1007\/s11096-018-0696-7","article-title":"PCNE definition of medication review: reaching agreement","volume":"40","author":"Griese-Mammen","year":"2018","journal-title":"Int J Clin Pharm"},{"key":"10.1053\/j.ajkd.2025.09.024_bib16","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1053\/j.ajkd.2024.08.005","article-title":"Acute kidney injury in care transitions (ACT): a randomized controlled feasibility trial","volume":"85","author":"Barreto","year":"2025","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2025.09.024_bib17","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1001\/jama.2015.18202","article-title":"Multinational assessment of accuracy of equations for predicting risk of kidney failure: a meta-analysis","volume":"315","author":"Tangri","year":"2016","journal-title":"JAMA"},{"key":"10.1053\/j.ajkd.2025.09.024_bib18","doi-asserted-by":"crossref","DOI":"10.1177\/20543581231215865","article-title":"Implementing a formalized risk-based approach to determine candidacy for multidisciplinary CKD care: a descriptive cohort study","volume":"10","author":"Donald","year":"2023","journal-title":"Can J Kidney Health Dis"},{"key":"10.1053\/j.ajkd.2025.09.024_bib19","doi-asserted-by":"crossref","DOI":"10.1177\/2054358117722782","article-title":"Risk-based triage for nephrology referrals using the kidney failure risk equation","volume":"4","author":"Hingwala","year":"2017","journal-title":"Can J Kidney Health Dis"},{"key":"10.1053\/j.ajkd.2025.09.024_bib20","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12882-019-1269-2","article-title":"Patient and provider experience and perspectives of a risk-based approach to multidisciplinary chronic kidney disease care: a mixed methods study","volume":"20","author":"Smekal","year":"2019","journal-title":"BMC Nephrol"},{"key":"10.1053\/j.ajkd.2025.09.024_bib21","series-title":"Medicare and Medicaid programs; conditions for coverage for end-stage renal disease facilities. 42 CFR Parts 405, 410, 413, 414, 488, and 494","year":"2008"},{"key":"10.1053\/j.ajkd.2025.09.024_bib22","series-title":"Requirements for approval and re-approval of transplant centers to perform organ transplants; final rule. 42 CFR Parts 405, 482, 488, and 498","year":"2007"},{"key":"10.1053\/j.ajkd.2025.09.024_bib23","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1177\/0897190010392235","article-title":"An evaluation of diabetes-related measures of control after 6 months of clinical pharmacy specialist intervention","volume":"24","author":"Cripps","year":"2011","journal-title":"J Pharm Pract"},{"key":"10.1053\/j.ajkd.2025.09.024_bib24","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s40271-013-0039-7","article-title":"Evaluation of patient satisfaction with diabetes management provided by clinical pharmacists in the patient-centered medical home","volume":"7","author":"McFarland","year":"2014","journal-title":"Patient"},{"key":"10.1053\/j.ajkd.2025.09.024_bib25","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/JHQ.0000000000000114","article-title":"Perceptions of integration of the clinical pharmacist into the patient care medical home model","volume":"40","author":"McFarland","year":"2018","journal-title":"J Healthc Qual"},{"key":"10.1053\/j.ajkd.2025.09.024_bib26","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/phar.1719","article-title":"Evaluation of the impact of a pharmacist-led telehealth clinic on diabetes-related goals of therapy in a veteran population","volume":"36","author":"Maxwell","year":"2016","journal-title":"Pharmacotherapy"},{"key":"10.1053\/j.ajkd.2025.09.024_bib27","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1016\/j.ajt.2023.08.004","article-title":"Results of a multicenter cluster-randomized controlled clinical trial testing the effectiveness of a bioinformatics-enabled pharmacist intervention in transplant recipients","volume":"23","author":"Taber","year":"2023","journal-title":"Am J Transplant"},{"key":"10.1053\/j.ajkd.2025.09.024_bib28","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1111\/ajt.16737","article-title":"Significant hospitalization cost savings to the payer with a pharmacist-led mobile health intervention to improve medication safety in kidney transplant recipients","volume":"21","author":"Taber","year":"2021","journal-title":"Am J Transplant"},{"key":"10.1053\/j.ajkd.2025.09.024_bib29","series-title":"The outcomes of implementing and integrating comprehensive medication management in team-based care: a review of the evidence on quality, access and costs","author":"McFarland","year":"2024"},{"key":"10.1053\/j.ajkd.2025.09.024_bib30","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1016\/j.jacc.2021.10.018","article-title":"The evolution of the quintuple aim","volume":"78","author":"Itchhaporia","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.ajkd.2025.09.024_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2022.100508","article-title":"Education standards for pharmacists providing comprehensive medication management in outpatient nephrology settings","volume":"4","author":"Hudson","year":"2022","journal-title":"Kidney Med"},{"key":"10.1053\/j.ajkd.2025.09.024_bib32","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.3390\/jcm13051367","article-title":"Type 2 diabetes and chronic kidney disease: an opportunity for pharmacists to improve outcomes","volume":"13","author":"Neumiller","year":"2024","journal-title":"J Clin Med"},{"key":"10.1053\/j.ajkd.2025.09.024_bib33","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2022-001979","article-title":"Multispecialty multidisciplinary input into comorbidities along with treatment optimisation in heart failure reduces hospitalisation and clinic attendance","volume":"9","author":"Essa","year":"2022","journal-title":"Open Heart"},{"key":"10.1053\/j.ajkd.2025.09.024_bib34","article-title":"Population health management and guideline-concordant care in CKD: a secondary analysis of kidney coordinated health management partnership","volume":"1","author":"Weltman","year":"2024","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2025.09.024_bib35","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1007\/s11096-019-00816-4","article-title":"Clinical pharmacy practice in the care of chronic kidney disease patients: a systematic review","volume":"41","author":"Al Raiisi","year":"2019","journal-title":"Int J Clin Pharm"},{"key":"10.1053\/j.ajkd.2025.09.024_bib36","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/ndt\/gfr287","article-title":"Pharmacists\u2019 interventions in the management of patients with chronic kidney disease: a systematic review","volume":"27","author":"Salgado","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ajkd.2025.09.024_bib37","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1592\/phco.29.12.1433","article-title":"Reduced drug use and hospitalization rates in patients undergoing hemodialysis who received pharmaceutical care: a 2-year, randomized, controlled study","volume":"29","author":"Pai","year":"2009","journal-title":"Pharmacotherapy"},{"key":"10.1053\/j.ajkd.2025.09.024_bib38","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s13300-023-01416-2","article-title":"Optimizing multidisciplinary care of patients with chronic kidney disease and type 2 diabetes mellitus","volume":"14","author":"Kelepouris","year":"2023","journal-title":"Diabetes Ther"},{"key":"10.1053\/j.ajkd.2025.09.024_bib39","first-page":"214","article-title":"Pharmacoequity measurement framework: a tool to reduce health disparities","volume":"31","author":"Patel","year":"2025","journal-title":"J Manag Care Spec Pharm"},{"issue":"5 suppl","key":"10.1053\/j.ajkd.2025.09.024_bib41","first-page":"S1","article-title":"KDIGO 2022 Clinical Practice Guideline for diabetes management in chronic kidney disease","volume":"102","year":"2022","journal-title":"Kidney Int"},{"issue":"4 suppl","key":"10.1053\/j.ajkd.2025.09.024_bib42","first-page":"S117","article-title":"KDIGO 2024 Clinical Practice Guideline for the evaluation and management of chronic kidney disease","volume":"105","year":"2024","journal-title":"Kidney Int"},{"issue":"2 suppl","key":"10.1053\/j.ajkd.2025.09.024_bib43","first-page":"S1","article-title":"KDIGO 2025 Clinical Practice Guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD)","volume":"107","year":"2025","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2025.09.024_bib45","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1161\/HYP.0000000000000232","article-title":"Implementation strategies to improve blood pressure control in the united states: a scientific statement from the American Heart Association and American Medical Association","volume":"80","author":"Abdalla","year":"2023","journal-title":"Hypertension"},{"key":"10.1053\/j.ajkd.2025.09.024_bib46","author":"Mott DA BB"},{"key":"10.1053\/j.ajkd.2025.09.024_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2022.100509","article-title":"Pharmacy practice standards for outpatient nephrology settings","volume":"4","author":"Cardone","year":"2022","journal-title":"Kidney Med"},{"key":"10.1053\/j.ajkd.2025.09.024_bib48","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/jac5.1796","article-title":"Collaboration between pharmacists in community pharmacy and ambulatory clinic settings: current state and future directions","volume":"6","author":"Cochran","year":"2023","journal-title":"J Am Coll Clin Pharm"},{"key":"10.1053\/j.ajkd.2025.09.024_bib49","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1331\/JAPhA.2008.08514","article-title":"Medication therapy management in pharmacy practice: core elements of an MTM service model (version 2.0)","volume":"48","year":"2008","journal-title":"J Am Pharm Assoc (2003)"},{"key":"10.1053\/j.ajkd.2025.09.024_bib50","first-page":"e39","article-title":"Collaborative drug therapy management and comprehensive medication management-2015","volume":"35","author":"McBane","year":"2015","journal-title":"Pharmacotherapy"},{"key":"10.1053\/j.ajkd.2025.09.024_bib51","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.amjmed.2020.12.008","article-title":"Assessing the impact of comprehensive medication management on achievement of the quadruple aim","volume":"134","author":"McFarland","year":"2021","journal-title":"Am J Med"},{"key":"10.1053\/j.ajkd.2025.09.024_bib54","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1177\/10600280241240409","article-title":"Role of a Pharmacist in postdischarge care for patients with kidney disease: a scoping review","volume":"58","author":"Manis","year":"2024","journal-title":"Ann Pharmacother"},{"key":"10.1053\/j.ajkd.2025.09.024_bib55","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1002\/jac5.1486","article-title":"Describing the delivery of clinical pharmacy services via telehealth: A systematic review","volume":"4","author":"Melton","year":"2021","journal-title":"J Am Coll Clin Pharm"},{"issue":"12","key":"10.1053\/j.ajkd.2025.09.024_bib56","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/ajhp\/zxaf048","article-title":"The pharmacist\u2019s role in transforming nephrology care","volume":"82","author":"Laub","year":"2025","journal-title":"Am J Health Syst Pharm"},{"key":"10.1053\/j.ajkd.2025.09.024_bib57","first-page":"zxaf046","article-title":"AKHOMM initiative curriculum and learning and action collaborative","volume":"2","author":"Meaney","year":"2025","journal-title":"Am J Health Syst Pharm"},{"key":"10.1053\/j.ajkd.2025.09.024_bib59","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/ajhp\/zxac104","article-title":"Barriers and facilitators to implementing pharmacist-provided comprehensive medication management in primary care transformation","volume":"79","author":"Pestka","year":"2022","journal-title":"Am J Health Syst Pharm"},{"key":"10.1053\/j.ajkd.2025.09.024_bib60","doi-asserted-by":"crossref","first-page":"605","DOI":"10.22454\/FamMed.2018.391124","article-title":"Pharmacist-delivered comprehensive medication management within family medicine practices: an evaluation of the SCRIPT project","volume":"50","author":"Castelli","year":"2018","journal-title":"Fam Med"},{"key":"10.1053\/j.ajkd.2025.09.024_bib61","doi-asserted-by":"crossref","first-page":"8","DOI":"10.37765\/ajac.2020.88356","article-title":"Implementation of pharmacist-driven comprehensive medication management as part of an interdisciplinary team in primary care physicians\u2019 offices","volume":"8","author":"Hatfield Sapp","year":"2020","journal-title":"Am J Accountable Care"},{"key":"10.1053\/j.ajkd.2025.09.024_bib63","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.japh.2023.11.003","article-title":"Why can\u2019t we be friends? The manufactured fear of pharmacist \u201cscope creep\u201d","volume":"64","author":"Covvey","year":"2024","journal-title":"J Am Pharm Assoc (2003)"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638625012120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638625012120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T09:24:05Z","timestamp":1773998645000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638625012120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0272638625012120"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2025.09.024","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimizing Comprehensive Medication Management in CKD: An Opportunity to Integrate Pharmacists in the Kidney Care Team","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2025.09.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}